Marino-Bravante, Gloria E. http://orcid.org/0000-0003-4733-0122
Carey, Alexis E.
Hüser, Laura http://orcid.org/0000-0001-7599-8192
Dixit, Agrani
Wang, Vania
Kaur, Amanpreet
Liu, Ying
Ding, Supeng http://orcid.org/0009-0005-3666-8269
Schnellmann, Rahel
Gerecht, Sharon http://orcid.org/0000-0002-8542-4835
Gu, Luo http://orcid.org/0000-0002-9813-7202
Eisinger-Mathason, T. S. Karin
Chhabra, Yash http://orcid.org/0000-0003-2883-4675
Weeraratna, Ashani T. http://orcid.org/0000-0003-0448-6952
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA232256, P01 CA114046, U01CA227550, 1F31CA261065, U01CA227550, T32CA153952)
Howard Hughes Medical Institute (GT15667)
Article History
Received: 14 June 2022
Accepted: 26 January 2024
First Online: 12 March 2024
Competing interests
: A.T.W. is on the board of ReGAIN Therapeutics, unrelated to the presented work. The remaining authors declare no competing interests.